Complications in Patients with COVID-19 - Reply

Mohammad Madjid, Scott D. Solomon, Orly Vardeny

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)359-360
Number of pages2
JournalJAMA cardiology
Volume6
Issue number3
DOIs
StatePublished - Mar 1 2021

Bibliographical note

Funding Information:
Conflict of Interest Disclosures: Dr Legrand has received research support from the French Ministry of Health and SphingoTec, lecture fees from Baxter and Fresenius, and consulting fees from Novartis.

Funding Information:
Conflict of Interest Disclosures: Dr Madjid has received personal fees as a speaker and consultant to Sanofi Pasteur. Dr Solomon has received research grants from Alnylam Pharmaceuticals, Amgen, AstraZeneca, Bellerophon Therapeutics, Bayer, Bristol Myers Squibb, Celladon, Cytokinetics, Eidos Therapeutics, Gilead Sciences, GlaxoSmithKline, Ionis Pharmaceuticals, Lone Star Heart and Vascular Center, Mesoblast, MyoKardia, Neurotronik, National Institutes of Health, National Heart, Lung, and Blood Institute, Novartis, Sanofi Pasteur, and Theracos and personal fees for consulting from Akros, Alnylam Pharmaceuticals, Amgen, Arena Pharmaceuticals, AstraZeneca, Bayer, Bristol Myers Squibb, Cardior Pharmaceuticals, Cardurion Pharmaceuticals, Corvia Medical, Cytokinetics, Daiichi Sankyo, Gilead Sciences, GlaxoSmithKline, Ironwood Pharmaceuticals, Merck, MyoKardia, Novartis, Roche, Sanofi Pasteur, Takeda, Theracos, Quantum Genetics, AOBiome, Janssen, Cardiac Dimensions, Tenaya Therapeutics, DiNAQOR, Tremeau Pharmaceuticals, CellProthera, and Moderna. Dr Vardeny has received research support from the National Institutes of Health and personal fees for consulting from Sanofi Pasteur.

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

PubMed: MeSH publication types

  • Journal Article
  • Comment

Cite this